
Psychiatr Serv 51:250-252, February 2000
© 2000 American Psychiatric Association
Effect of Clozapine on Polypharmacy
Siow-Ann Chong, M.B.B.S., M.Med.(Psychiatry),
Gary J. Remington, M.D., Ph.D. and
Kalyna Z. Bezchlibnyk-Butler, Bsc.Phm.
Prescribing patterns for a group of outpatients with schizophrenia were surveyed for changes after the initiation of clozapine. Data were drawn from computerized pharmacy records, direct case record reviews, and interviews with the attending psychiatrists. The number of patients with two or more psychotropic drugs decreased by 31 percent after the initiation of clozapine, and a trend toward the use of clozapine without additional neuroleptics was detected. Decreases occurred in the use of anticholinergic agents, carbamazepine, and benzodiazepines, but selective serotonin reuptake inhibitors and sodium valproate were more likely to be prescribed concomitantly with clozapine.
This article has been cited by other articles:

|
 |

|
 |
 
M. Horvitz-Lennon, J. M. Donohue, M. E. Domino, and S.-L. T. Normand
Improving Quality And Diffusing Best Practices: The Case Of Schizophrenia
Health Aff.,
May 1, 2009;
28(3):
701 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|